Sfoglia per AUTORE
BONORA S
Collezione ASL Città di Torino

  

Items : 141

Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2025 Mar 3;80(3):610-623. doi: 10.1093/jac/dkaf025.
2025
ASL Città di Torino

Lo Caputo S; Guaraldi G; Gianotti N; Di Biagio A; Cingolani A; Bonora S; Taramasso L; Madeddu G; Maggi P; Marchetti G; Nozza S; Rusconi S; Maggiolo F;

How Antiretroviral Drug Concentrations Could Be Affected by Oxidative Stress, Physical Capacities and Genetics: A Focus on Dolutegravir Treated Male PLWH. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2025 Jan 13;14(1):82. doi: 10.3390/antiox14010082.
2025
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Lupo C; Rainoldi A; Di Perri G; Bonora S; Trevisan G; Cuomo S; Tettoni MC; Chiara F; Mula J; Antonucci M; Bianco G; Accardo G; Palermiti A; Ferrara M; Manca A; Mulasso A; Cusato J;

The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognition. in bioRxiv : the preprint server for biology / bioRxiv [Preprint]. 2025 Feb 28:2025.02.28.640732. doi: 10.1101/2025.02.28.640732.
2025
ASL Città di Torino

Trunfio M; Scutari R; Fox V; Vuaran E; Dastgheyb RM; Fini V; Granaglia A; Balbo F; Tortarolo D; Bonora S; Perno CF; Di Perri G; Alteri C; Calcagno A;

Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug-Drug Interactions. in Pharmaceutics / Pharmaceutics. 2025 Feb 14;17(2):250. doi: 10.3390/pharmaceutics17020250.
2025
ASL Città di Torino

Billi M; Soloperto S; Bonora S; D'Avolio A; De Nicolò A;

Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):180-191. doi: 10.1097/QAI.0000000000003480.
2024
ASL Città di Torino

Calcagno A; Di Perri G; Bonora S; Trentalange A; Giaccone C; Trunfio M; Noce G; Ghisetti V; Tettoni MC; Nigra M; Guastamacchia G; Stroffolini G; Pirriatore V; Barco A; Vai D; Lazzaro A;

Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study. in AIDS and behavior / AIDS Behav. 2024 Nov;28(11):3643-3654. doi: 10.1007/s10461-024-04440-w. Epub 2024 Jul 30.
2024
ASL Città di Torino

Calcagno A; Letendre SL; Bonora S; Di Perri G; Cinnirella G; Imperiale D; Di Stefano A; Quarta C; Vuaran E; Vai D; Trunfio M;

Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIV. in AIDS (London, England) / AIDS. 2024 Mar 15;38(4):477-486. doi: 10.1097/QAD.0000000000003775. Epub 2023 Nov 7.
2024
ASL Città di Torino
AOU Città della Salute di Torino

Calcagno A; Di Perri G; Letendre SL; Bonora S; Imperiale D; Cavallo R; Pittaluga F; Croce M; Trunfio M; Sacchi A; Vai D;

Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Jun;63(6):107137. doi: 10.1016/j.ijantimicag.2024.107137. Epub 2024 Ma
2024
ASL Città di Torino

D'Avolio A; Di Perri G; Bonora S; Trunfio M; Antonucci M; Marinaro L; Avataneo V; Mula J; Palermiti A; Manca A; Cusato J; Calcagno A;

Further considerations on the use of cerebrospinal fluid C-X-C motif chemokine ligand 13 in the diagnosis of neurosyphilis among people with HIV. in AIDS (London, England) / AIDS. 2024 Jul 1;38(8):1273-1275. doi: 10.1097/QAD.0000000000003902. Epub 2024 May 30.
2024
ASL Città di Torino

Trunfio M; Bonora S; di Perri G; Calcagno A;

2024
ASL Città di Torino

Maggiolo F; Lo Caputo S; Bonora S; Borderi M; Cingolani A; D'Ettorre G; Di Biagio A; Di Giambenedetto S; Gervasoni C; Guaraldi G; Maggi P; Taramasso L;

Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO(2) Requirements. in Microorganisms / Microorganisms. 2024 Aug 26;12(9):1767. doi: 10.3390/microorganisms12091767.
2024
ASL Città di Torino

Neuenschwander FC; Barnett-Griness O; Piconi S; Maor Y; Sprinz E; Assy N; Khmelnitskiy O; Lomakin NV; Goloshchekin BM; Nahorecka E; Joaquim Westheimer Calvacante A; Ivanova A; Vladimirovich Zhuravel S; Yurevna Trufanova G; Bonora S; Saffoury A; Mayo A; Shvarts YG; Rizzardini G; Sobroza de Mello R; Pilau J; Klinov A; Valente-Acosta B; Olegovich Burlaka O; Bakhtina N; Bar-Meir M; Nikolaevich Shishimorov I; Oñate-Gutierrez J; García Rincón CI; et alii...

Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual Therapy. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2024 Apr 26;13(5):518. doi: 10.3390/antiox13050518.
2024
ASL Città di Torino
AOU San Luigi di Orbassano

Rainoldi A; D'Avolio A; Di Perri G; Lupo C; Bonora S; Trevisan G; Cuomo S; Maddalone MG; Tettoni MC; Mula J; Chiara F; Bianco G; Accardo G; Palermiti A; Antonucci M; Ferrara M; Manca A; Mulasso A; Cusato J;

Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Sep 19;12(9):1460. doi: 10.3390/antibiotics12091460.
2023
ASL Asti
ASL Città di Torino

Calcagno A; Bonora S; De Rosa FG; Gregorc V; Frascione PMM; Allice T; Ponzetta L; Vita D; Pepe A; Lupia T; Ranzani FA; Gaviraghi A; Venuti F; Longo BM;

Pillars of long-term antiretroviral therapy success. in Pharmacological research / Pharmacol Res. 2023 Oct;196:106898. doi: 10.1016/j.phrs.2023.106898. Epub 2023 Aug 28.
2023
ASL Città di Torino

Taramasso L; Andreoni M; Antinori A; Bandera A; Bonfanti P; Bonora S; Borderi M; Castagna A; Cattelan AM; Celesia BM; Cicalini S; Cingolani A; Cossarizza A; D'Arminio Monforte A; D'Ettorre G; Di Biagio A; Di Giambenedetto S; Di Perri G; Esposito V; Focà E; Gervasoni C; Gori A; Gianotti N; Guaraldi G; Gulminetti R; Lo Caputo S; Madeddu G; Maggi P; Marandola G; et alii...

COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
2023
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Bonora S; Di Perri G; Ferrara M; De Vivo ED; Maiese D; Antonucci M; Chiara F; Costanzo M; Mula J; Manca A; Palermiti A; Cusato J;

A Novel UHPLC-MS/MS Method for the Quantification of Seven Opioids in Different Human Tissues. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2023 Jun 19;16(6):903. doi: 10.3390/ph16060903.
2023
ASL Città di Torino

Manca A; De Nicolò A; De Vivo ED; Ferrara M; Oh S; Khalili S; Higgins N; Deiss RG; Bonora S; Cusato J; Palermiti A; Mula J; Gianella S; D'Avolio A;

Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman. in Virology journal / Virol J. 2023 Jun 13;20(1):123. doi: 10.1186/s12985-023-02086-z.
2023
ASL Città di Torino

Calcagno A; Di Perri G; Fantino S; Alladio F; Burdino E; Allice T; Longo BM; Trevisan G; Ferrara M; Di Girolamo L; Bonora S;

Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Jun;18(1-2):169-182. doi: 10.1007/s11481-023-10066-x. Epub 2023 May 11
2023
ASL Città di Torino

Calcagno A; Di Perri G; Bonora S; Nigra M; Guastamacchia G; Atzori C; Mighetto L; Napoli L; Trunfio M;

2023
ASL Città di Torino

Bonora S; Cinnirella G; D'Avolio A; Marchiaro C; Catellani E; Romano F; Quaranta M; Ranzani FA; Di Vincenzo A; Longo BM; Stroffolini G; De Nicolò A; Gaviraghi A; Venuti F; Calcagno A;

Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Jan 12;13(2):295. doi: 10.3390/diagnostics13020295.
2023
ASL Città di Torino

D'Avolio A; Bonora S; Mula J; Di Perri G; Manca A; Palermiti A; Marinaro L; Trunfio M; Antonucci M; Avataneo V; Cusato J; Calcagno A;

2023
ASL Città di Torino

Pennati F; Calza S; Di Biagio A; Mussini C; Rusconi S; Bonora S; Borghetti A; Quiros-Roldan E; Sarteschi G; Menozzi M; Ferrara M; Celotti A; Ciccullo A; Giacomet V; Izzo I; Dotta L; Badolato R; Castelli F; Focà E;

Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Dec;18(4):551-562. doi: 10.1007/s11481-023-10086-7. Epub 2023 Oct 31.
2023
ASL Città di Torino

Calcagno A; Di Perri G G; Bonora S; Trunfio M; Nigra M; Atzori C; Giaccone C; Vai D; Pirriatore V; Barco A; Lazzaro A; Stroffolini G;

Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect? in Therapeutic drug monitoring / Ther Drug Monit. 2023 Apr 1;45(2):282-284. doi: 10.1097/FTD.0000000000001072. Epub 2023 Jan 10.
2023
ASL Città di Torino

Cattaneo D; Bonora S; Meraviglia P; Vimercati S; Antinori S; Gervasoni C;

2023
ASL Città di Torino

Antinori A; Bonora S; Ghisetti V; Focà E; D'Arminio Monforte A; Vera JH; D'Ettorre G; Celani L; Bai F; Arsuffi S; Pinnetti C; Trunfio M; Calcagno A;

2022
ASL Città di Torino

Di Perri G; Calcagno A; Cortese G; Bonora S; Traverso F; Nespoli P; Portesani F; Vicinanza S; Trunfio M;

Trichinella britovi outbreak in Piedmont, North-West Italy, 2019-2020: Clinical and epidemiological insights in the one health perspective. in Travel medicine and infectious disease / Travel Med Infect Dis. 2022 May-Jun;47:102308. doi: 10.1016/j.tmaid.2022.102308. Epub 2022 Mar 9.
2022
ASL Asti
ASL Città di Torino
ASL Torino 3

Stroffolini G; Calleri G; Di Perri G; Bonora S; Calcagno A; Paltrinieri G; Lipani F; Lupia T; Faraoni S; Rossi L;

Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options. in Microorganisms / Microorganisms. 2022 Jun 23;10(7):1275. doi: 10.3390/microorganisms10071275.
2022
ASL Città di Torino
AOU Città della Salute di Torino

Calcagno A; Di Perri G; Bonora S; Rugge W; Scabini S; Trunfio M;

Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV. in AIDS and behavior / AIDS Behav. 2022 Jul;26(7):2203-2211. doi: 10.1007/s10461-021-03563-8. Epub 2022 Jan 4.
2022
ASL Città di Torino

Di Perri G; Calcagno A; Bonora S; Imperiale D; Domini S; Alcantarini C; Milesi M; Medina C; De Francesco D; Vai D; Trunfio M;

Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patient. in International journal of STD & AIDS / Int J STD AIDS. 2022 Jan;33(1):94-96. doi: 10.1177/09564624211048343. Epub 2021 Oct 11.
2022
ASL Città di Torino

Parietti M; Trunfio M; Delmonte S; Conti L; Trentalange A; Bonora S; Calcagno A; Ribero S;

Oral doxycycline in HIV-related synchronous malignant syphilis and condyloma lata. in Italian journal of dermatology and venereology / Ital J Dermatol Venerol. 2022 Dec;157(6):524-525. doi: 10.23736/S2784-8671.22.07232-2.
2022
ASL Città di Torino
AOU Città della Salute di Torino

Ribero S; Quaglino P; Fierro MT; Marra E; Conti L; Senetta R; Rugge W; Calleri G; Bonora S; Trunfio M; Mastorino L; Susca S; Cavallo F; Avallone G;

Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2022 Aug;32(8):1936-1943. doi: 10.1016/j.numecd.2022.05.004. Epub 2022 Ma
2022
ASL Città di Torino

Barale M; Massano M; Bioletto F; Maiorino F; Pusterla A; Mazzetti R; Trentini L; Bonora S; Di Perri G; Ghigo E; Procopio M;

2022
ASL Città di Torino

Di Perri G; Bonora S; Nigra M; Imperiale D; Vai D; Di Stefano A; Atzori C; Pasquero M; Trunfio M; Calcagno A;

2022
ASL Città di Torino

Bonora S; Trunfio M; Noce G; Atzori C; Guastamacchia G; Vai D; Lazzaro A; Pirriatore V; Stroffolini G; Orlando S; Barco A; Di Perri G; Calcagno A;

Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases. in Frontiers in microbiology / Front Microbiol. 2022 Apr 1;13:829393. doi: 10.3389/fmicb.2022.829393. eCollection 2022.
2022
ASL Città di Torino

Trunfio M; Richiardi L; Alladio F; Staffilano E; Longo B; Venuti F; Ghisetti V; Burdino E; Bonora S; Vineis P; Di Perri G; Calcagno A;

BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors. in Le infezioni in medicina / Infez Med. 2022 Jun 1;30(2):242-246. doi: 10.53854/liim-3002-9. eCollection 2022.
2022
ASL Città di Torino

De Benedetto I; Barco A; Rossi M; Lapadula G; Lupia T; Bonfanti P; Bonora S; Di Perri G; Calcagno A;

Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART). The first reported case in Italy. in Journal of preventive medicine and hygiene / J Prev Med Hyg. 2022 Oct 27;63(3):E420-E423. doi: 10.15167/2421-4248/jpmh2022.63.3.2137. eCollection
2022
ASL Città di Torino

Mastroianni A; Vangeli V; Greco S; Chidichimo L; Urso F; Mauro MV; Bonora S; DE Nicolò A; D'Avolio A;

2021
ASL Città di Torino

Di Perri G; Bonora S; Emanuele T; Burdino E; Verga F; Ghisetti V; Trunfio M; Calcagno A;

The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study. in Open forum infectious diseases / Open Forum Infect Dis. 2021 Apr 28;8(11):ofab217. doi: 10.1093/ofid/ofab217. eCollection 2021 Nov.
2021
ASL Città di Torino

Sepulcri C; Dentone C; Mikulska M; Bruzzone B; Lai A; Fenoglio D; Bozzano F; Bergna A; Parodi A; Altosole T; Delfino E; Bartalucci G; Orsi A; Di Biagio A; Zehender G; Ballerini F; Bonora S; Sette A; De Palma R; Silvestri G; De Maria A; Bassetti M;

2021
ASL Città di Torino

De Nicolò A; Manca A; Ianniello A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;

Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 May 12;11(5):867. doi: 10.3390/diagnostics11050867.
2021
ASL Città di Torino

Calcagno A; Di Perri G; Imperiale D; Bonora S; Atzori C; Nigra M; Cusato J; Ghisetti V; Trunfio M; Caligaris G;

Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe
2021
ASL Città di Torino

Bonora S; Di Perri G; D'Avolio A; Piccioni P; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Motta I; Borgogno E; Trentalange A; Calcagno A;

The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries. in Microorganisms / Microorganisms. 2021 Jul 31;9(8):1648. doi: 10.3390/microorganisms9081648.
2021
ASL Città di Torino
AOU Città della Salute di Torino

Castelnuovo B; Bonora S; Di Perri G; Pirriatore V; Alcantarini C; Rugge W; Mornese Pinna S; Scabini S; Trunfio M; Calcagno A;

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases. in The Lancet. Infectious diseases / Lancet Infect Dis. 2021 Jul;21(7):914-915. doi: 10.1016/S1473-3099(21)00205-X. Epub 2021 Apr 14.
2021
ASL Città di Torino

Trunfio M; Calcagno A; Bonora S; Di Perri G;

Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino

Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S; D'Avolio A; Di Perri G;

Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):103-109. doi: 10.1007/s40262-020-00916-9.
2021
ASL Città di Torino

Calcagno A; Moltó J; Borghetti A; Gervasoni C; Milesi M; Valle M; Avataneo V; Alcantarini C; Pla-Junca F; Trunfio M; D'Avolio A; Di Giambenedetto S; Cattaneo D; Di Perri G; Bonora S;

2021
ASL Città di Torino

Di Perri G; Bonora S; Picco C; Bertucci R; Ghisetti V; Cerutti F; Burdino E; Longo BM; Alladio F; Venuti F; Trunfio M; Calcagno A;

Co-infection with other respiratory pathogens in COVID-19 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2021 Feb;27(2):297-298. doi: 10.1016/j.cmi.2020.08.012. Epub 2020 Aug 19.
2021
ASL Città di Torino

Boglione L; Bonora S; Allice T; Trunfio M; Burdino E; Ghisetti V; Calcagno A; Di Perri G; Calcagno A; Ghisetti V; Burdino E; Trunfio M; Allice T; Boglione L; Bonora S; Di Perri G;

On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. in Frontiers in microbiology / Front Microbiol. 2021 Mar 16;12:646679. doi: 10.3389/fmicb.2021.646679. eCollection 2021.
2021
ASL Città di Torino

Trunfio M; Longo BM; Alladio F; Venuti F; Cerutti F; Ghisetti V; Bonora S; Di Perri G; Calcagno A;

A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs. in Journal of neurovirology / J Neurovirol. 2020 Oct;26(5):642-651. doi: 10.1007/s13365-020-00874-9. Epub 2020 Jul 31.
2020
ASL Città di Torino

Calcagno A; Guastamacchia G; Bonora S; Trunfio M; De Benedetto I;

Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1899-1906. doi: 10.1097/QAD.0000000000002601.
2020
ASL Città di Torino

Calcagno A; Di Perri G; Guastamacchia G; Bonora S; Borgogno E; Domini S; Atzori C; Nigra M; Mighetto L; Vai D; Rugge W; Trunfio M;

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino

Sciascia S; Aprà F; Baffa A; Baldovino S; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Cinnirella G; Converso M; Cozzi M; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Giusti M; Imperiale D; Imperiale G; Livigni S; Manno E; Massara C; Milone V; Natale G; Navarra M; Oddone V; Osella S; Piccioni P; et alii...

Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation. in AIDS (London, England) / AIDS. 2020 Mar 1;34(3):373-380. doi: 10.1097/QAD.0000000000002442.
2020
ASL Città di Torino

Di Perri G; Calcagno A; Bonora S; Ghisetti V; Lipani F; Gregori G; Pirriatore V; Mighetto L; Imperiale D; Gianella S; Audagnotto S; Atzori C; Milia MG; Lupia T;

Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):290-294. doi: 10.1097/QAI.0000000000002331.
2020
ASL Città di Torino

Gori A; Antinori A; Vergori A; Cossu MV; Menzaghi B; Sterrantino G; Rusconi S; Cattelan AM; Castelli F; Gianotti N; Orofino G; Ripamonti D; Savinelli S; Manzillo E; Santantonio TA; Celesia BM; Cauda R; Maserati R; d'Arminio Monforte A; Stingone C; Bonora S; Uglietti A; Termini R; Rucci F; Mancusi D;

Cerebral white matter Hyperintensities in HIV-positive patients. in Brain imaging and behavior / Brain Imaging Behav. 2020 Feb;14(1):10-18. doi: 10.1007/s11682-018-9966-1.
2020
ASL Città di Torino

Di Perri G; Bonora S; Barco A; Nunnari G; Tettoni M; Imperiale D; Cusato J; Prochet A; Trentalange A; Calcagno A;

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino

De Nicolò A; Ianniello A; Ferrara M; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. in Thrombosis research / Thromb Res. 2020 Dec;196:432-434. doi: 10.1016/j.thromres.2020.09.039. Epub 2020 Oct 8.
2020
ASL Città di Torino

Bonora S; Roccatello D; Sciascia S; Lipani F; Gaviraghi A; Trentalange A; Marinaro L; Alcantarini C; Cabodi D; Salvador E; Trunfio M; Di Perri G; Calcagno A;

Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients. in The pharmacogenomics journal / Pharmacogenomics J. 2020 Apr;20(2):202-212. doi: 10.1038/s41397-019-0109-x. Epub 2019 Oct 16.
2020
ASL Città di Torino

Cusato J; Calcagno A; Marinaro L; Avataneo V; D?Avolio A; Di Perri G; Bonora S;

Safety and efficacy of daclatasvir at doses other than 60?mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2020 Apr;52(4):447-451. doi: 10.1016/j.dld.2019.12.007. Epub 2020 Jan 17.
2020
ASL Città di Torino

Rossotti R; Tavelli A; Bonora S; Cingolani A; Lo Caputo S; Saracino A; Soria A; Marinaro L; Uberti-Foppa C; Mussini C; Puoti M; d'Arminio Monforte A;

Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity. in Antiviral therapy / Antivir Ther. 2020;25(6):327-333. doi: 10.3851/IMP3377.
2020
ASL Città di Torino

Trunfio M; Salvador E; Gaviraghi A; Audagnotto S; Marinaro L; Motta I; Casciaro R; Ghisetti V; Fava C; Bonora S; Di Perri G; Calcagno A;

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2019 Nov;25(11):1443-1446. doi: 10.1016/j.cmi.2019.07.004. Epub 2019 Jul 25.
2019
ASL Città di Torino

Ungaro R; Taramasso L; Bruzzone B; Vicenti I; Galli L; Borghi V; Francisci D; Pecorari M; Zoncada A; Callegaro AP; Paolini E; Monno L; Bonora S; Di Biagio A;

HIV-1 detection in the olfactory mucosa of HIV-1-infected participants. in AIDS (London, England) / AIDS. 2019 Mar 15;33(4):665-674. doi: 10.1097/QAD.0000000000002102.
2019
ASL Città di Torino

Di Perri G; Calcagno A; Bonora S; Amasio E; Zanusso G; Ghisetti V; Pirriatore V; Kincer LP; Imperiale D; Cassoni P; Catera S; Trunfio M; Allice T; Joseph SB; Bertero L;

2019
ASL Città di Torino

Castagna A; Rusconi S; Gulminetti R; Bonora S; Mazzola G; Quiros-Roldan ME; De Socio GV; Ladisa N; Carosella S; Cattelan A; Di Giambenedetto S; Mena M; Poli A; Galli L; Riva A;

Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino

Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;

The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes. in Journal of neurovirology / J Neurovirol. 2019 Dec;25(6):887-892. doi: 10.1007/s13365-019-00769-4. Epub 2019 Jun 18.
2019
ASL Città di Torino

Di Perri G; Taraglio S; Bonora S; Imperiale D; Audagnotto S; Boghi A; Trentalange A; Manini C; Trunfio M; Calcagno A;

Malignant Melanoma in People Living with HIV/AIDS: Can We Know More, Can We Do Better? in AIDS reviews / AIDS Rev. 2019;21(2):65-75. doi: 10.24875/AIDSRev.19000038.
2019
ASL Città di Torino

Trunfio M; Ribero S; Bonora S; Di Perri G; Quaglino P; Calcagno A;

2018
ASL Città di Torino

Taramasso L; Di Biagio A; Maggiolo F; Tavelli A; Lo Caputo S; Bonora S; Zaccarelli M; Caramello P; Costantini A; Viscoli C; d'Arminio Monforte A; Cozzi-Lepri A;

2018
ASL Città di Torino

Di Perri G; Imperiale D; Bonora S; Audagnotto S; Orofino G; Tettoni MC; Livelli A; Alcantarini C; Vai D; Montrucchio C; Trunfio M; Calcagno A;

2018
ASL Città di Torino

Motta I; Trunfio M; Calcagno A; Pirriatore V; Scabini S; Palazzo A; Audagnotto S; Fatiguso G; Liberini V; Bellò M; D'Avolio A; Di Perri G; Bonora S;

CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose. in Current HIV/AIDS reports / Curr HIV/AIDS Rep. 2018 Feb;15(1):84-91. doi: 10.1007/s11904-018-0375-2.
2018
ASL Città di Torino

Calcagno A; Barco A; Trunfio M; Bonora S;

Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino

Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;

The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment. in Antiviral therapy / Antivir Ther. 2018;23(5):451-456. doi: 10.3851/IMP3221.
2018
ASL Città di Torino

Bigliano P; Calcagno A; Lucchini A; Audagnotto S; Montrucchio C; Marinaro L; Alcantarini C; Ghisetti V; Di Perri G; Bonora S;

Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy? in Journal of neurovirology / J Neurovirol. 2017 Oct;23(5):763-767. doi: 10.1007/s13365-017-0549-5. Epub 2017 Jul 5.
2017
ASL Città di Torino

Di Perri G; Bonora S; Lipani F; Prochet A; Audagnotto S; Ghisetti V; Imperiale D; Milia MG; Scarvaglieri E; Mornese Pinna S; Calcagno A;

2017
ASL Città di Torino

Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A;

Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2017 Mar;12(1):187-193. doi: 10.1007/s11481-016-9717-2. Epub 2016 Nov 8.
2017
ASL Città di Torino

Di Perri G; Imperiale D; Lipani F; Scarvaglieri E; Audagnotto S; Cardellino C; Ghisetti V; Atzori C; Romito A; Calcagno A; Bonora S;

Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. in Pharmacogenomics / Pharmacogenomics. 2017 Jun;18(9):865-880. doi: 10.2217/pgs-2017-0176. Epub 2017 Jun 8.
2017
ASL Città di Torino

Allegra S; Fatiguso G; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Di Perri G; D'Avolio A;

Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter study. in Journal of cardiovascular medicine (Hagerstown, Md.) / J Cardiovasc Med (Hagerstown). 2017 Jul;18(7):539-544. doi: 10.2459/JCM.0000000000000436.
2017
ASL Città di Torino
AOU Città della Salute di Torino

Mancone M; Ballocca F; Grosso Marra W; Calcagno A; D'Ettorre G; Cannillo M; D'Ascenzo F; Gili S; Orofino G; Marruncheddu L; Lonni E; Cinque A; Vullo F; Ceccarelli G; Vilardi I; Sardella G; Vullo V; Moretti C; Fedele F; Bonora S; Gaita F;

Treating HIV Infection in the Central Nervous System. in Drugs / Drugs. 2017 Feb;77(2):145-157. doi: 10.1007/s40265-016-0678-9.
2017
ASL Città di Torino

Calcagno A; Di Perri G; Bonora S;

Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.
2017
ASL Città di Torino

Marinaro L; Calcagno A; Ripamonti D; Cenderello G; Pirriatore V; Trentini L; Salassa B; Bramato C; Orofino G; D'Avolio A; Rizzi M; Di Perri G; Rusconi S; Bonora S;

Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs. in Clinical pharmacokinetics / Clin Pharmacokinet. 2017 Apr;56(4):355-369. doi: 10.1007/s40262-016-0456-6.
2017
ASL Città di Torino

Calcagno A; Cusato J; D'Avolio A; Bonora S;

Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy. in PloS one / PLoS One. 2017 Dec 18;12(12):e0189425. doi: 10.1371/journal.pone.0189425. eCollection 2017.
2017
ASL Città di Torino

Pittalis S; Piselli P; Contini S; Gualano G; Alma MG; Tadolini M; Piccioni P; Bocchino M; Matteelli A; Bonora S; Di Biagio A; Franzetti F; Carbonara S; Gori A; Sotgiu G; Palmieri F; Ippolito G; Girardi E;

Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia. in Antiviral therapy / Antivir Ther. 2017;22(6):539-543. doi: 10.3851/IMP3140. Epub 2017 Feb 15.
2017
ASL Città di Torino

Bonora S; Di Perri G; Ghisetti V; Imperiale D; Ecclesia S; Ferrara M; Romito A; Allice T; Motta I; Calcagno A;

High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders. in Current HIV research / Curr HIV Res. 2017;15(4):258-265. doi: 10.2174/1570162X15666170531085838.
2017
ASL Città di Torino

Calcagno A; Lucchini A; Caracciolo D; Balbiano R; Bracchi M; Sordella F; Gregori G; Lipani F; Audagnotto S; Chiriotto M; Cavaglia G; Ghisetti V; Di Perri G; Bonora S;

2017
ASL Città di Torino

Di Biagio A; Riccardi N; Signori A; Maserati R; Nozza S; Gori A; Bonora S; Borderi M; Ripamonti D; Rossi MC; Orofino G; Quirino T; Nunnari G; Celesia BM; Martini S; Sagnelli C; Mazzola G; Colletti P; Bartolozzi D; Bini T; Ladisa N; Castelnuovo F; Saracino A; Lo Caputo S;

Zika virus infection in two travelers returning from an epidemic area to Italy, 2016: Algorithm for diagnosis and recommendations. in Travel medicine and infectious disease / Travel Med Infect Dis. 2016 Sep-Oct;14(5):506-508. doi: 10.1016/j.tmaid.2016.07.001. Epub 2016 Jul 9
2016
ASL Città di Torino

Calleri G; Burdino E; Bonora S; Raso R; Ghisetti V; Caramello P;

HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era. in Progress in cardiovascular diseases / Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):565-76. doi: 10.1016/j.pcad.2016.02.008. Epub 2016 Mar 2.
2016
ASL Città di Torino
AOU Città della Salute di Torino

Moretti C; Coppola J; Bonora S; Flammer A; Calcagno A; Cannillo M; Marra WG; D'Ascenzo F; Gili S; Ballocca F; Gaita F;

Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study. in International journal of pharmaceutics / Int J Pharm. 2016 Jan 30;497(1-2):287-92. doi: 10.1016/j.ijpharm.2015.11.044. Epub 2015 Nov 28.
2016
ASL Città di Torino

Bonora S; Perri GD; Cusato J; Favata F; Motta I; Baietto L; Calcagno A; Allegra S; Fatiguso G; D'Avolio A;

Efavirenz pharmacogenetics in a cohort of Italian patients. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 De
2016
ASL Città di Torino

Di Perri G; Leggieri A; Allegra S; Marinaro L; Bonora S; Calcagno A; Simiele M; Tomasello C; Cusato J; D'Avolio A; Cusato J; Tomasello C; Simiele M; Calcagno A; Bonora S; Marinaro L; Leggieri A; Allegra S; Di Perri G; D'Avolio A;

Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients. in Journal of neurovirology / J Neurovirol. 2016 Feb;22(1):88-92. doi: 10.1007/s13365-015-0371-x. Epub 2015 Aug 6.
2016
ASL Città di Torino

Di Perri G; Imperiale D; Montrucchio C; Stella ML; Vai D; Audagnotto S; Romito A; Atzori C; Calcagno A; Bonora S; Calcagno A; Atzori C; Romito A; Vai D; Audagnotto S; Stella ML; Montrucchio C; Imperiale D; Di Perri G; Bonora S;

Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis. in European heart journal / Eur Heart J. 2016 Dec 21;37(48):3600-3609. doi: 10.1093/eurheartj/ehv734. Epub 2016 Feb 6.
2016
ASL Città di Torino
AOU Città della Salute di Torino

Gasparini M; Bonora S; Omedè P; Montefusco A; Lavie CJ; DiNicolantonio JJ; Mancone M; Barbero U; Pianelli M; Cerrato E; Ballocca F; Cannillo M; Calcagno A; Lonni E; D'Ascenzo F; Grosso Marra W; Gili S; Biondi-Zoccai G; Moretti C; Gaita F; Gili S; Grosso Marra W; D'Ascenzo F; Lonni E; Calcagno A; Cannillo M; Ballocca F; Cerrato E; Pianelli M; et alii...

HCV NS3 naturally occurring variants in HIV/HCV coinfected DAA-naïve patients: consideration for HCV genotyping resistance testing. in Infection / Infection. 2016 Dec;44(6):789-792. doi: 10.1007/s15010-016-0937-4. Epub 2016 Aug 13.
2016
ASL Città di Torino

Ruggiero T; Burdino E; Calcagno A; Bonora S; Boglione L; Di Perri G; Ghisetti V;

Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics. in Current HIV research / Curr HIV Res. 2016;14(1):54-60. doi: 10.2174/1570162x13666150929112135.
2016
ASL Città di Torino

Calcagno A; Montrucchio C; Capetti A; Guaraldi G; Cenderello G; Calza L; Lanzafame M; Marinaro L; Tettoni MC; Trentini L; D'Avolio A; Di Perri G; Bonora S;

Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis. in Antiviral therapy / Antivir Ther. 2016;21(7):633-635. doi: 10.3851/IMP3032. Epub 2016 Feb 9.
2016
ASL Città di Torino

Bonora S; Busolli P; Atzori C; Ghisetti V; Calcagno A; Trentalange A; Imperiale D;

A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Sep;70(9):2572-5. doi: 10.1093/jac/dkv148. Epub 2015 Jun 11.
2015
ASL Città di Torino

Baietto L; Calcagno A; Motta I; Baruffi K; Poretti V; Di Perri G; Bonora S; D'Avolio A;

A LC-MS method to quantify tenofovir urinary concentrations in treated patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:8-11. doi: 10.1016/j.jpba.2015.05.001. Epub 2015 May 8.
2015
ASL Città di Torino

Simiele M; Carcieri C; De Nicolò A; Ariaudo A; Sciandra M; Calcagno A; Bonora S; Di Perri G; D'Avolio A;

2015
ASL Città di Torino

Andreoni M; Marcotullio S; Puro V; De Carli G; Tambussi G; Nozza S; Gori A; Rusconi S; Santoro MM; Clementi M; Perno CF; d'Arminio Monforte A; Maggiolo F; Castagna A; De Luca A; Galli M; Giacomelli A; Borderi M; Guaraldi G; Calcagno A; Di Perri G; Bonora S; Mussini C; Di Biagio A; Puoti M; Bruno R; Zuccaro V; Antinori A; Cinque P; et alii...

HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients. in AIDS research and human retroviruses / AIDS Res Hum Retroviruses. 2015 Oct;31(10):999-1008. doi: 10.1089/AID.2015.0102. Epub 2015 Aug 6.
2015
ASL Città di Torino

Calcagno A; Motta I; Ghisetti V; Lo Re S; Allice T; Marinaro L; Milia MG; Tettoni MC; Trentini L; Orofino G; Salassa B; Di Perri G; Bonora S;

Class-specific relative genetic contribution for key antiretroviral drugs. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Nov;70(11):3074-9. doi: 10.1093/jac/dkv207. Epub 2015 Jul 28.
2015
ASL Città di Torino

Siccardi M; Olagunju A; Simiele M; D'Avolio A; Calcagno A; Di Perri G; Bonora S; Owen A;

2015
ASL Città di Torino

Ruggiero T; Proietti A; Boglione L; Milia MG; Allice T; Burdino E; Orofino G; Bonora S; Di Perri G; Ghisetti V;

High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis. in Atherosclerosis / Atherosclerosis. 2015 May;240(1):197-204. doi: 10.1016/j.atherosclerosis.2015.03.019. Epub 2015 Mar
2015
ASL Città di Torino

D'Ascenzo F; Cerrato E; Calcagno A; Grossomarra W; Ballocca F; Omedè P; Montefusco A; Veglia S; Barbero U; Gili S; Cannillo M; Pianelli M; Mistretta E; Raviola A; Salera D; Garabello D; Mancone M; Estrada V; Escaned J; De Marie D; Abbate A; Bonora S; Zoccai GB; Moretti C; Gaita F;

Heart failure in patients with human immunodeficiency virus: a review of the literature. in Journal of cardiovascular medicine (Hagerstown, Md.) / J Cardiovasc Med (Hagerstown). 2015 May;16(5):383-9. doi: 10.2459/JCM.0000000000000168.
2015
ASL Città di Torino

Cannillo M; D'Ascenzo F; Grosso Marra W; Cerrato E; Calcagno A; Omedè P; Bonora S; Mancone M; Vizza D; DiNicolantonio JJ; Pianelli M; Barbero U; Gili S; Annone U; Raviola A; Salera D; Mistretta E; Vilardi I; Colaci C; Abbate A; Zoccai GB; Moretti C; Gaita F;

Pharmacokinetic and pharmacodynamic evaluation of raltegravir and experience from clinical trials in HIV-positive patients. in Expert opinion on drug metabolism & toxicology / Expert Opin Drug Metab Toxicol. 2015 Jul;11(7):1167-76. doi: 10.1517/17425255.2015.1056732.
2015
ASL Città di Torino

Calcagno A; D'Avolio A; Bonora S;

Acute HIV infection: improved algorithms for HIV testing. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2015 Feb;63:51-2. doi: 10.1016/j.jcv.2014.12.007. Epub 2014 Dec 12.
2015
ASL Città di Torino

Ghisetti V; Calcagno A; Burdino E; Orofino G; Bonora S;

Cardiovascular disease in HIV patients: from bench to bedside and backwards. in Open heart / Open Heart. 2015 Mar 20;2(1):e000174. doi: 10.1136/openhrt-2014-000174. eCollection 2015.
2015
ASL Città di Torino

Cerrato E; Calcagno A; D'Ascenzo F; Biondi-Zoccai G; Mancone M; Grosso Marra W; Demarie D; Omedè P; Abbate A; Bonora S; DiNicolantonio JJ; Estrada V; Escaned J; Moretti C; Gaita F;

Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy. in PloS one / PLoS One. 2015 May 1;10(5):e0124252. doi: 10.1371/journal.pone.0124252. eCollection 2015.
2015
ASL Città di Torino

Bandera A; Gori A; Sabbatini F; Madeddu G; Bonora S; Libertone R; Mastroianni C; Bonfanti P; d'Arminio Monforte A; Cozzi-Lepri A;

Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Sep;69(9):2586-8. doi: 10.1093/jac/dku142. Epub 2014 May 8.
2014
ASL Città di Torino

Calcagno A; Nozza S; Simiele M; Milia MG; Chiappetta S; D'Avolio A; Ghisetti V; Lazzarin A; Di Perri G; Bonora S;

2014
ASL Città di Torino
AOU Città della Salute di Torino

DiNicolantonio JJ; Omedè P; Fedele F; Sardella G; Vignali L; Mancone M; Manga P; Vachiat A; Parodi G; Santilli F; Tamburino C; Capodanno D; Belli R; Chinaglia A; Cassese S; Kastrati A; Escaned J; Das Neves B; Carrie D; Lhermusier T; Abouzaki N; Vetrovec G; Calcagno A; Moretti C; Appleton D; Cerrato E; D'Ascenzo F; Bonora S; Gaita F; et alii...

Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system. in Clinical pharmacokinetics / Clin Pharmacokinet. 2014 Oct;53(10):891-906. doi: 10.1007/s40262-014-0171-0.
2014
ASL Città di Torino

Calcagno A; Di Perri G; Bonora S;

Prevalence and predictors of blood-brain barrier damage in the HAART era. in Journal of neurovirology / J Neurovirol. 2014 Oct;20(5):521-5. doi: 10.1007/s13365-014-0266-2. Epub 2014 Jun 28.
2014
ASL Città di Torino

Calcagno A; Alberione MC; Romito A; Imperiale D; Ghisetti V; Audagnotto S; Lipani F; Raviolo S; Di Perri G; Bonora S;

Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Nov;69(11):3061-6. doi: 10.1093/jac/dku234. Epub 2014 Jul 4.
2014
ASL Città di Torino

D'Avolio A; Carcieri C; Cusato J; Simiele M; Calcagno A; Allegra S; Sciandra M; Trentini L; Di Perri G; Bonora S;

A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Jun;94:65-70. doi: 10.1016/j.jpba.2014.01.031. Epub 2014 Jan 31.
2014
ASL Città di Torino

Simiele M; Baietto L; Audino A; Sciandra M; Bonora S; Di Perri G; D'Avolio A;

Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitor regimens. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2014 Jul;58(7):4042-7. doi: 10.1128/AAC.00104-14. Epub 2014 May 5.
2014
ASL Città di Torino

De Nicolò A; Simiele M; Calcagno A; Abdi AM; Bonora S; Di Perri G; D'Avolio A;

Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction. in Pharmacogenomics / Pharmacogenomics. 2014 Jul;15(10):1281-6. doi: 10.2217/pgs.14.92.
2014
ASL Città di Torino

Calcagno A; Baietto L; Pagani N; Simiele M; Audagnotto S; D'Avolio A; De Rosa FG; Di Perri G; Bonora S;

Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients. in Antiviral research / Antiviral Res. 2014 Aug;108:44-7. doi: 10.1016/j.antiviral.2014.05.009. Epub 2014 May 23.
2014
ASL Città di Torino

Calcagno A; Marinaro L; Nozza S; Aldieri C; Carbone A; Ghisetti V; Trentalange A; D'Avolio A; Castagna A; Di Perri G; Bonora S;

Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19719. doi: 10.7448/IAS.17.4.19719. eCollection 2014.
2014
ASL Città di Torino

Calcagno A; Atzori C; Romito A; Ecclesia S; Imperiale D; Audagnotto S; Alberione MC; Trentalange A; Di Perri G; Bonora S;

Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome. in BMC anesthesiology / BMC Anesthesiol. 2014 May 21;14:37. doi: 10.1186/1471-2253-14-37. eCollection 2014.
2014
ASL Città di Torino

De Rosa FG; Fanelli V; Corcione S; Urbino R; Bonetto C; Ricci D; Rinaldi M; Di Perri G; Bonora S; Ranieri MV;

Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients. in Current HIV research / Curr HIV Res. 2014;12(5):339-46. doi: 10.2174/1570162x12666140807151616.
2014
ASL Città di Torino

Bonora S; Calcagno A; Vigano O; Bigliano P; Marinaro L; Colella E; Orofino G; Trentini L; Tettoni MC; D'Avolio A; Mercadante S; Galli M; Di Perri G; Rusconi S;

Evaluation of a rapid antigen and antibody combination test in acute HIV infection. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2013 May;57(1):84-7. doi: 10.1016/j.jcv.2013.01.007. Epub 2013 Feb 4.
2013
ASL Città di Torino

Faraoni S; Rocchetti A; Gotta F; Ruggiero T; Orofino G; Bonora S; Ghisetti V;

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2013 Apr;68(4):907-10. doi: 10.1093/jac/dks484. Epub 2012 Dec 5.
2013
ASL Città di Torino

D'Avolio A; Simiele M; Calcagno A; Siccardi M; Larovere G; Agati S; Baietto L; Cusato J; Tettoni M; Sciandra M; Trentini L; Di Perri G; Bonora S;

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Jul;66:376-80. doi: 10.1016/j.jpba.2012.03.030. Epub 2012 Mar 28.
2012
ASL Città di Torino

D'Avolio A; De Nicolò A; Simiele M; Turini S; Agnesod D; Boglione L; Cusato J; Baietto L; Cariti G; Calcagno A; Sciandra M; Di Perri G; Bonora S;

2012
ASL Città di Torino

Bonora S; Calcagno A; Cometto C; Fontana S; Aguilar D; D'Avolio A; Gonzalez de Requena D; Maiello A; Dal Conte I; Lucchini A; Di Perri G;

Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment. in Therapeutic drug monitoring / Ther Drug Monit. 2012 Dec;34(6):722-8. doi: 10.1097/FTD.0b013e318272e55a.
2012
ASL Città di Torino

D'Avolio A; Ciancio A; Siccardi M; Smedile A; Simiele M; Cusato J; Baietto L; Aguilar Marucco D; Cariti G; Calcagno A; Gonzalez de Requena D; Sciandra M; Troshina G; Caviglia GP; Bonora S; Rizzetto M; Di Perri G;

2012
ASL Città di Torino

D?Avolio A; Ciancio A; Siccardi M; Smedile A; Baietto L; Simiele M; Marucco DA; Cariti G; Calcagno A; de Requena DG; Sciandra M; Cusato J; Troshina G; Bonora S; Rizzetto M; Di Perri G;

A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2011 Mar 25;54(4):779-88. doi: 10.1016/j.jpba.2010.10.011. Epub 2010 Nov 10.
2011
ASL Città di Torino

D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Oddone V; Stefani FR; Agati S; Cusato J; Bonora S; Di Perri G;

Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2011 Jun;55(6):2976-8. doi: 10.1128/AAC.01236-10. Epub 2011 Mar 14.
2011
ASL Città di Torino

Simiele M; D'Avolio A; Baietto L; Siccardi M; Sciandra M; Agati S; Cusato J; Bonora S; Di Perri G;

2011
ASL Città di Torino

Bonora S; Gonzalez de Requena D; D'Avolio A; Calcagno A; Tettoni M; Siccardi M; Baietto L; Simiele M; Trentini L; Di Perri G;

HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2010 Sep 5;52(5):774-80. doi: 10.1016/j.jpba.2010.02.026. Epub 2010 Feb 25.
2010
ASL Città di Torino

D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Bonora S; Di Perri G;

Magnetic-silica based nucleic acid extraction for Human Immunodeficiency Virus Type-1 drug-resistance testing in low viremic patients. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2010 Jan;47(1):8-12. doi: 10.1016/j.jcv.2009.10.012. Epub 2009 Nov 14.
2010
ASL Città di Torino

Milia MG; Allice T; Gregori G; Mussino S; Orofino G; Bonora S; Ghisetti V;

A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2010 Feb;32(1):86-92. doi: 10.1097/FTD.0b013e3181cacbd0.
2010
ASL Città di Torino

D'Avolio A; Simiele M; Baietto L; Siccardi M; Sciandra M; Patanella S; Bonora S; Di Perri G;

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2010 Dec;20(12):759-65. doi: 10.1097/FPC.0b013e3283402efb.
2010
ASL Città di Torino

Siccardi M; D'Avolio A; Nozza S; Simiele M; Baietto L; Stefani FR; Moss D; Kwan WS; Castagna A; Lazzarin A; Calcagno A; Bonora S; Back D; Di Perri G; Owen A;

Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2008 Nov 1;47(9):1222-5. doi: 10.1086/592304.
2008
ASL Città di Torino

Siccardi M; D'Avolio A; Baietto L; Gibbons S; Sciandra M; Colucci D; Bonora S; Khoo S; Back DJ; Di Perri G; Owen A;

A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients. in Journal of chromatographic science / J Chromatogr Sci. 2008 Jul;46(6):524-8. doi: 10.1093/chromsci/46.6.524.
2008
ASL Città di Torino

D'Avolio A; Sciandra M; Siccardi M; Baietto L; Gonzalez de Requena D; Bonora S; Di Perri G;

Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins. in The Journal of infection / J Infect. 2008 Jul;57(1):78-81. doi: 10.1016/j.jinf.2008.05.005. Epub 2008 Jun 11.
2008
ASL Città di Torino

Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G;

A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting. in Therapeutic drug monitoring / Ther Drug Monit. 2008 Feb;30(1):90-4. doi: 10.1097/FTD.0b013e31815f4f7e.
2008
ASL Città di Torino

D'Avolio A; Baietto L; De Rosa FG; Garazzino S; Sciandra M; Siccardi M; Bonora S; Di Perri G;

2008
ASL Città di Torino

D'Avolio A; Baietto L; Siccardi M; Sciandra M; Simiele M; Oddone V; Bonora S; Di Perri G;

HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Nov 15;859(2):234-40. doi: 10.1016/j.jchromb.200
2007
ASL Città di Torino

D'Avolio A; Siccardi M; Sciandra M; Baietto L; Bonora S; Trentini L; Di Perri G;

Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2007 Mar;59(3):565-8. doi: 10.1093/jac/dkl497. Epub 2007 Jan 9.
2007
ASL Città di Torino

Aguilar Marucco D; Veronese L; de Requena DG; Bonora S; Calcagno A; Cavecchia I; Sinicco A; De Rosa FG; Cariti G; Di Perri G;

A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):374-8. doi: 10.1016/j.jchromb.2006.
2007
ASL Città di Torino

D'Avolio A; Sciandra M; Siccardi M; Baietto L; de Requena DG; Bonora S; Di Perri G;

Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient. in The Journal of infection / J Infect. 2006 Nov;53(5):e215-8. doi: 10.1016/j.jinf.2006.01.023. Epub 2006 Mar 20.
2006
ASL Città di Torino

De Rosa FG; Audagnotto S; Bargiacchi O; Garazzino S; Aguilar Marucco D; Veronese L; Canta F; Bonora S; Sinicco A; Di Perri G;

Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 1;835(1-2):127-30. doi: 10.1016/j.jchromb.20
2006
ASL Città di Torino

D'Avolio A; Ibañez A; Sciandra M; Siccardi M; de Requena DG; Bonora S; Di Perri G;

An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2006 Feb;28(1):110-5. doi: 10.1097/01.ftd.0000179421.25337.62.
2006
ASL Città di Torino

D'Avolio A; Sciandra M; de Requena DG; Ibañez A; Bonora S; Di Perri G;

Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2004 Sep;54(3):593-602. doi: 10.1093/jac/dkh377. Epub 2004 Jul 28.
2004
ASL Città di Torino

Di Perri G; Bonora S;